pipeline coverage and competitive landscape

Launch of DelveInsight’s Antibody-Drug Conjugate Report DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-dr...

Gene Therapy: The “Hunt” for CNS disorders! Many companies have tried over the years to find a way to reverse the course of crippling central nervous system disorders like amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s disease) but have failed. Fortunately, Gene therapy has proven to be an answer to a wide ran...

Gene Therapy's breakthrough in the field of Otolaryngology! About Otolaryngology Otolaryngology encompasses the treatment of many diverse conditions, including: dizziness, hearing loss, problems of the larynx and sinus, difficulties swallowing, tumors of the auditory nerve, and voice production etc. Gene Therapy...

Gene Therapy: The “Cure” for Cancer! About Gene Therapy Gene Therapy involves using drugs that are aimed at specific genes or proteins that are only found in cancer cells or the tissue environment that contributes to cancer growth and survival. Put simply, it injects these genes into the tiny cells, with the help ...